Some accumulation on this Canadian biotech.

On January 18, André Desmarais bought 100,000 shares at $18.20.

Between April 7 and 10, Denis Garceau bought 19,500 shares at an average cost of $15.24.

On March 2, Frederick Iowy bought 1,000 shares at $16.60.

Salutations,

G.L.